A California jury on Tuesday discovered Bayer liable in a case introduced by a person who claimed his most cancers was resulting from publicity to the corporate’s Roundup weed killer, and ordered it to pay $332 million in damages.
The decision consists of $7 million in compensatory damages and $325 million in punitive damages awarded to plaintiff Mike Dennis, who was recognized at age 51 with a type of non-Hodgkin lymphoma, in accordance with a spokesperson for the corporate.
The punitive injury award is nearly sure to be diminished sharply, because the U.S. Supreme Courtroom has discovered that punitive damages ought to be lower than 10 instances the compensatory damages in just about all instances.
The jury sided with Bayer on two of 4 authorized claims within the case, the spokesperson mentioned, discovering that whereas the corporate had did not warn of Roundup’s dangers, it had not been negligent and the product was not defectively designed.
The corporate mentioned in a press release that it has “robust arguments on attraction to get this unfounded verdict overturned and the unconstitutionally extreme injury award eradicated or diminished, given that there have been important and reversible authorized and evidentiary errors made throughout this trial.“
A lawyer for Dennis didn’t instantly reply to a request for remark.
This marks the third trial loss for Bayer this month, after being hit by a $175 million verdict and a $1.25 million verdict in two separate Roundup trials. Earlier than that, it had received 9 consecutive trials over related claims.
Roundup-related lawsuits have dogged Bayer because it acquired the model as a part of its $63 billion buy of Monsanto in 2018. The corporate settled most Roundup claims towards it in 2020 for as much as $10.9 billion, however nonetheless faces near 40,000 Roundup-related instances.
Was this text worthwhile?
Listed below are extra articles it’s possible you’ll get pleasure from.
Crucial insurance coverage information,in your inbox each enterprise day.
Get the insurance coverage business’s trusted publication